Phase 1 Malignant ascites Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor Necrosis Factor or Bevacizumab for the Treatment of Malignant Ascites Following Failure of Prior Standard Therapy
Malignant ascites
Dong sheng Zhang48 enrolled1 locationNCT07397819
Recruiting
Phase 1
A Phase I Study of SIM0388 in Participants With Malignant Ascites.
Malignant ascites
Jiangsu Simcere Pharmaceutical Co., Ltd.50 enrolled1 locationNCT07007988
Recruiting
Phase 1
Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer
Malignant Pleural EffusionMalignant ascites
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)12 enrolled1 locationNCT06016179
Terminated
Phase 1
A phase Ia study of MRC202 in patients with malignant ascites caused by cancer.
Malignant ascites (hydoperitoneum) associated with cancer
MRC Biotech Pty Ltd12 enrolled1 locationACTRN12607000078459